A Phase II Study of Fingolimod in Patients with Non-Small Cell and Small Cell Lung Cancer
- Sponsor:
- MUSC
- Sponsor Study ID:
- 103909
- CTO #:
- 103909
- NCT Number:
- NCT06424067
- Phase:
- II
- Protocol Type:
- Treatment
- Age Group:
- Adults
- Disease Sites:
- Lung
- Study Objectives:
- To determine the safety and tolerability of fingolimod in patients with NSCLC and SCLC. To evaluate the objective response rate (ORR) (when measurable) according to RECIST 1.1 criteria
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Alexander, Mariam, at alexanma@musc.edu .
- Study Coordinator, Shealor, Jessica, at shealorj@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina